1. Home
  2. NRXP vs XBP Comparison

NRXP vs XBP Comparison

Compare NRXP & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • XBP
  • Stock Information
  • Founded
  • NRXP 2015
  • XBP N/A
  • Country
  • NRXP United States
  • XBP United Kingdom
  • Employees
  • NRXP N/A
  • XBP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • XBP Business Services
  • Sector
  • NRXP Health Care
  • XBP Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • XBP Nasdaq
  • Market Cap
  • NRXP 34.7M
  • XBP 40.1M
  • IPO Year
  • NRXP N/A
  • XBP N/A
  • Fundamental
  • Price
  • NRXP $2.01
  • XBP $1.34
  • Analyst Decision
  • NRXP Strong Buy
  • XBP
  • Analyst Count
  • NRXP 4
  • XBP 0
  • Target Price
  • NRXP $28.25
  • XBP N/A
  • AVG Volume (30 Days)
  • NRXP 185.3K
  • XBP 31.3K
  • Earning Date
  • NRXP 05-13-2025
  • XBP 03-19-2025
  • Dividend Yield
  • NRXP N/A
  • XBP N/A
  • EPS Growth
  • NRXP N/A
  • XBP N/A
  • EPS
  • NRXP N/A
  • XBP N/A
  • Revenue
  • NRXP N/A
  • XBP $142,772,000.00
  • Revenue This Year
  • NRXP N/A
  • XBP N/A
  • Revenue Next Year
  • NRXP N/A
  • XBP N/A
  • P/E Ratio
  • NRXP N/A
  • XBP N/A
  • Revenue Growth
  • NRXP N/A
  • XBP N/A
  • 52 Week Low
  • NRXP $1.10
  • XBP $0.79
  • 52 Week High
  • NRXP $6.01
  • XBP $4.33
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 42.26
  • XBP 54.81
  • Support Level
  • NRXP $1.95
  • XBP $1.17
  • Resistance Level
  • NRXP $2.12
  • XBP $1.40
  • Average True Range (ATR)
  • NRXP 0.18
  • XBP 0.15
  • MACD
  • NRXP 0.01
  • XBP 0.01
  • Stochastic Oscillator
  • NRXP 23.08
  • XBP 82.98

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: